SCHEDULE 13G

AN2 Therapeutics, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 037326105

Event date: 2026-03-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 2,135,044.00 · Class: 6.0%

• Millennium Management LLC

  Shares: 2,237,102.00 · Class: 6.3%

• Millennium Group Management LLC

  Shares: 2,237,102.00 · Class: 6.3%

• Israel A. Englander

  Shares: 2,237,102.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.